Horn L - Search Results

1

Phase II study of bendamustine in relapsed chemotherapy sensitive or resistant small-cell lung cancer.

Lammers PE, Shyr Y, Li CI, Hutchison AS, Sandler A, Carbone DP, Johnson DH, Keedy VL, Horn L. Lammers PE, et al. Among authors: horn l. J Thorac Oncol. 2014 Apr;9(4):559-62. doi: 10.1097/JTO.0000000000000079. J Thorac Oncol. 2014. PMID: 24736081 Free PMC article. Clinical Trial.

2

Chemotherapy and antiangiogenic agents in non-small-cell lung cancer.

Horn L, Sandler A. Horn L, et al. Clin Lung Cancer. 2007 Feb;8 Suppl 2:S68-73. doi: 10.3816/clc.2007.s.004. Clin Lung Cancer. 2007. PMID: 17382027 Review.

3

The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer.

Horn L, Sandler AB, Putnam JB Jr, Johnson DH. Horn L, et al. J Thorac Oncol. 2007 May;2(5):377-83. doi: 10.1097/01.JTO.0000268669.64625.bb. J Thorac Oncol. 2007. PMID: 17473651 Free article.

4

Lung cancer adjuvant therapy.

Horn L, Sandler A. Horn L, et al. Cancer J. 2007 May-Jun;13(3):210-6. doi: 10.1097/PPO.0b013e318074d8f6. Cancer J. 2007. PMID: 17620772 Review.

5

Evarts A. Graham and the first pneumonectomy for lung cancer.

Horn L, Johnson DH. Horn L, et al. J Clin Oncol. 2008 Jul 1;26(19):3268-75. doi: 10.1200/JCO.2008.16.8260. J Clin Oncol. 2008. PMID: 18591561 No abstract available.

6

A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.

Horn L, Bernardo P, Sandler A, Wagner H, Levitan N, Levitt ML, Johnson DH. Horn L, et al. J Thorac Oncol. 2009 Apr;4(4):527-33. doi: 10.1097/JTO.0b013e31819c7daf. J Thorac Oncol. 2009. PMID: 19240650 Free PMC article. Clinical Trial.

7

Angiogenesis in the treatment of non-small cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Proc Am Thorac Soc. 2009 Apr 15;6(2):206-17. doi: 10.1513/pats.200807-066LC. Proc Am Thorac Soc. 2009. PMID: 19349490 Free PMC article. Review.

8

Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.

Horn L, Sandler AB. Horn L, et al. Clin Lung Cancer. 2009 Mar;10 Suppl 1(Suppl 1):S7-16. doi: 10.3816/CLC.2009.s.002. Clin Lung Cancer. 2009. PMID: 19362948 Free PMC article. Review.

9

Targeting the eicosanoid pathway in non-small-cell lung cancer.

Horn L, Backlund M, Johnson DH. Horn L, et al. Expert Opin Ther Targets. 2009 Jun;13(6):675-88. doi: 10.1517/14728220902915567. Epub 2009 May 2. Expert Opin Ther Targets. 2009. PMID: 19409031 Free PMC article. Review.

10

Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.

Horn L, Sandler A. Horn L, et al. Clin Cancer Res. 2009 Aug 15;15(16):5040-8. doi: 10.1158/1078-0432.CCR-09-0520. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671872 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,353 results

Search Page

Filters